Sage Therapeutics, Inc. (SAGE) Social Stream
SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts
Use the tables below to see what analysts covering SAGE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 20 | $105 | $48 | $73.368 | $26.37 | 178.23% |
| 2021-12-20 | 19 | $105 | $48 | $72.842 | $26.37 | 176.23% |
| 2022-01-12 | 19 | $105 | $48 | $73.157 | $26.37 | 177.43% |
| 2022-01-26 | 17 | $105 | $48 | $73.157 | $26.37 | 177.43% |
| 2022-02-16 | 18 | $105 | $48 | $72.315 | $26.37 | 174.23% |
| 2022-02-25 | 18 | $105 | $48 | $71.736 | $26.37 | 172.04% |
| 2022-02-28 | 17 | $105 | $48 | $70.055 | $26.37 | 165.66% |
| 2022-03-21 | 17 | $105 | $40 | $68.722 | $26.37 | 160.61% |
| 2022-04-01 | 18 | $105 | $37 | $67.052 | $26.37 | 154.27% |
| 2022-05-03 | 18 | $105 | $37 | $67.21 | $26.37 | 154.87% |
| 2022-05-04 | 18 | $105 | $37 | $65.7 | $26.37 | 149.15% |
| 2022-05-06 | 18 | $105 | $37 | $64.631 | $26.37 | 145.09% |
| 2022-05-10 | 18 | $105 | $37 | $64.421 | $26.37 | 144.3% |
| 2022-05-24 | 19 | $105 | $37 | $64.85 | $26.37 | 145.92% |
| 2022-06-01 | 19 | $105 | $37 | $65 | $26.37 | 146.49% |
| 2022-06-13 | 18 | $105 | $36 | $63.5 | $26.37 | 140.8% |
| 2022-07-21 | 18 | $105 | $36 | $61 | $26.37 | 131.32% |
| 2022-08-03 | 18 | $105 | $36 | $57.941 | $26.37 | 119.72% |
| 2022-08-04 | 18 | $105 | $36 | $59.611 | $26.37 | 126.06% |
| 2022-09-19 | 18 | $105 | $36 | $59.5 | $26.37 | 125.64% |
| 2022-10-17 | 16 | $105 | $36 | $59.5 | $26.37 | 125.64% |
| 2022-11-01 | 14 | $105 | $36 | $59.111 | $26.37 | 124.16% |
| 2022-11-08 | 17 | $105 | $36 | $59.111 | $26.37 | 124.16% |
| 2022-11-11 | 18 | $105 | $36 | $57 | $26.37 | 116.15% |
| 2022-11-21 | 20 | $105 | $36 | $56.85 | $26.37 | 115.59% |
| 2022-12-07 | 20 | $105 | $36 | $55 | $26.37 | 108.57% |
| 2023-02-06 | 20 | $105 | $36 | $55.3 | $26.37 | 109.71% |
| 2023-02-17 | 20 | $105 | $36 | $55.5 | $26.37 | 110.47% |
| 2023-02-21 | 21 | $105 | $36 | $56.05 | $26.37 | 112.55% |
| 2023-03-10 | 21 | $105 | $36 | $56.1 | $26.37 | 112.74% |
| 2023-03-13 | 22 | $105 | $36 | $56.285 | $26.37 | 113.44% |
| 2023-05-03 | 22 | $105 | $36 | $57.65 | $26.37 | 118.62% |
| 2023-05-04 | 22 | $105 | $40 | $57.8 | $26.37 | 119.19% |
| 2023-05-09 | 22 | $105 | $40 | $56.894 | $26.37 | 115.75% |
| 2023-05-22 | 22 | $105 | $40 | $57.75 | $26.37 | 119% |
| 2023-06-15 | 21 | $105 | $40 | $57.473 | $26.37 | 117.95% |
| 2023-07-09 | 21 | $105 | $40 | $57.21 | $26.37 | 116.95% |
| 2023-07-23 | 20 | $105 | $40 | $58.166 | $26.37 | 120.58% |
| 2023-08-02 | 20 | $105 | $37 | $57.777 | $26.37 | 119.1% |
| 2023-08-07 | 20 | $105 | $37 | $56.611 | $26.37 | 114.68% |
| 2023-08-08 | 22 | $105 | $18 | $36.7 | $26.37 | 39.17% |
| 2023-08-09 | 21 | $79 | $18 | $33.578 | $26.37 | 27.33% |
| 2023-08-22 | 22 | $79 | $18 | $31.631 | $26.37 | 19.95% |
| 2023-09-01 | 22 | $79 | $18 | $31.736 | $26.37 | 20.35% |
| 2023-09-05 | 22 | $79 | $18 | $31.3 | $26.37 | 18.7% |
| 2023-10-08 | 23 | $79 | $18 | $30.571 | $26.37 | 15.93% |
| 2023-10-13 | 23 | $79 | $18 | $30.714 | $26.37 | 16.47% |
| 2023-11-07 | 22 | $79 | $18 | $30.2 | $26.37 | 14.52% |
| 2023-11-09 | 22 | $79 | $18 | $30.15 | $26.37 | 14.33% |
| 2023-11-29 | 22 | $79 | $18 | $26.944 | $26.37 | 2.18% |
| 2023-12-15 | 22 | $79 | $18 | $25.388 | $26.37 | -3.72% |
| 2023-12-18 | 22 | $79 | $18 | $25.388 | $26.37 | -3.72% |
| 2023-12-29 | 22 | $79 | $18 | $25.277 | $26.37 | -4.14% |
The Trend in the Analyst Price Target
SAGE's average price target has moved down $32.42 over the prior 33 weeks.
Over the past 49 weeks, SAGE's average upside potential has been 46.1%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-13 | 21 | 105 | 36 | 56.285 | 43.36 | 29.81% |
| 2023-08-09 | 21 | 79 | 18 | 33.578 | 18.99 | 76.82% |
| 2023-11-07 | 22 | 79 | 18 | 30.200 | 19.63 | 53.85% |
| 2023-11-29 | 22 | 79 | 18 | 26.944 | 19.48 | 38.32% |
| 2023-12-26 | 22 | 79 | 18 | 25.277 | 22.17 | 14.01% |
SAGE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.64 | 4 | 0 | 18 | 0 | 0 | 22 |
The Trend in the Broker Recommendations
SAGE's average broker recommendation rating worsened by 1.09 over the prior 45 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SAGE THERAPEUTICS INC's variance in analysts' estimates is lower than -6500.5% of all US stocks.
- In the context of stocks in the mid market cap category, SAGE THERAPEUTICS INC's number of analysts covering the stock is higher than 7110.21% of them.
- In terms of how SAGE THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 5308.24% of that group.
- In terms of how SAGE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 5084.53% of that group.
Stocks similar to SAGE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AMPH, FGEN, and TARO.
View All Top Stocks by Price Target
Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.